Prevention of Chemotherapy Induced Neuropathy
Phase 2
- Conditions
- chemotherapy induced neuropathy.Other antineoplastic drugs
- Registration Number
- IRCT2017021132494N1
- Lead Sponsor
- Bakhtar Bioshimi Company
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- Female
- Target Recruitment
- 40
Inclusion Criteria
Inclusion criteria : Women who have pathologically confirmed non metatstatic breast cancer; aged 18-65; candidate for receiving 4 course of paclitaxel ; good performance status (based on Karnofsky Score)
Exclusion criteria : history of diabetes mellitus; previous neuropathy; chronic renal or liver disease; consumption of neurotoxic/neurotropic/neuroleptic drugs
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Taxane induced neuropathy. Timepoint: befor and after each chemotherapy session. Method of measurement: taking history and physical exam.
- Secondary Outcome Measures
Name Time Method Objective neuropathy. Timepoint: befor begining chemotherapy session and 6 week after last chemotherapy session. Method of measurement: nerve conducting study.